FDA grants accelerated approval to afamitresgene autoleucel, an engineered cell therapy, for synovial sarcoma
Evidence stage: Emerging ClinicalRegulatory status: FDA Approved
Afamitresgene autoleucel is an engineered T-cell therapy — reportedly the first engineered cell therapy approved for a solid tumor in the United States — that received accelerated approval based on…
Primary source cited
Last reviewed